Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/16/24 17:06 | 5/14/24 | RGNX | Health | BioPrd | Biological Products, (No Diag | Mills Kenneth T. | MD | DO | P,CEO | 6 | M.d | 1,007 | 11.19 | 0 | 90 | 28 | 408 | D | ||||||||||||||
5/16/24 17:06 | 5/14/24 | RGNX | Health | BioPrd | Biological Products, (No Diag | Mills Kenneth T. | MD | DO | P,CEO | 6 | S.d | -1,007 | 11.19 | 0 | -90 | 408 | D | |||||||||||||||
3/21/24 17:20 | 3/19/24 | RGNX | Health | BioPrd | Biological Products, (No Diag | Vasista Vittal | MD | O | CFO | 1 | M.d | 75 | 3.76 | 0 | 20 | 9 | 247 | D | ||||||||||||||
3/7/24 18:05 | 3/5/24 | RGNX | Health | BioPrd | Biological Products, (No Diag | Pakola Steve | MD | O | Chief Me | 2 | M.d | 652 | 25.31 | 0 | 26 | 32 | 107 | D | ||||||||||||||
3/7/24 18:05 | 3/5/24 | RGNX | Health | BioPrd | Biological Products, (No Diag | Pakola Steve | MD | O | Chief Me | 2 | S.d | -652 | 25.31 | 0 | -26 | 107 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |